Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities
R Duncan, MJ Vicent - Advanced drug delivery reviews, 2010 - Elsevier
N-(2-Hydroxypropyl) methacrylamide (HPMA) copolymer conjugates containing doxorubicin
designed in the late 1970s/early 1980s as anticancer polymer therapeutics were the first …
designed in the late 1970s/early 1980s as anticancer polymer therapeutics were the first …
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities
R Duncan, MJ Vicent - Advanced Drug Delivery Reviews, 2010 - infona.pl
N-(2-Hydroxypropyl) methacrylamide (HPMA) copolymer conjugates containing doxorubicin
designed in the late 1970s/early 1980s as anticancer polymer therapeutics were the first …
designed in the late 1970s/early 1980s as anticancer polymer therapeutics were the first …
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities.
R Duncan, MJ Vicent - Advanced Drug Delivery Reviews, 2009 - europepmc.org
N-(2-Hydroxypropyl) methacrylamide (HPMA) copolymer conjugates containing doxorubicin
designed in the late 1970s/early 1980s as anticancer polymer therapeutics were the first …
designed in the late 1970s/early 1980s as anticancer polymer therapeutics were the first …
[引用][C] Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities
R DUNCAN, MJ VICENT - Advanced drug delivery reviews, 2010 - pascal-francis.inist.fr
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical
overview of current status and future opportunities CNRS Inist Pascal-Francis CNRS Pascal …
overview of current status and future opportunities CNRS Inist Pascal-Francis CNRS Pascal …
[引用][C] Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities☆
R Duncan, MJ Vicent - Advanced Drug Delivery Reviews, 2010 - cir.nii.ac.jp
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical
overview of current status and future opportunities☆ | CiNii Research CiNii 国立情報学研究所 …
overview of current status and future opportunities☆ | CiNii Research CiNii 国立情報学研究所 …
[PDF][PDF] Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities☆
R Duncan, MJ Vicent - Advanced Drug Delivery Reviews, 2010 - academia.edu
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical
overview of current status and future Page 1 Commentary Do HPMA copolymer conjugates …
overview of current status and future Page 1 Commentary Do HPMA copolymer conjugates …
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities
R Duncan, MJ Vicent - Advanced drug delivery reviews, 2010 - pubmed.ncbi.nlm.nih.gov
N-(2-Hydroxypropyl) methacrylamide (HPMA) copolymer conjugates containing doxorubicin
designed in the late 1970s/early 1980s as anticancer polymer therapeutics were the first …
designed in the late 1970s/early 1980s as anticancer polymer therapeutics were the first …